China Jo-Jo Drugstores In...

NASDAQ: CJJD · Real-Time Price · USD
1.52
-0.09 (-5.59%)
At close: Mar 03, 2025, 3:58 PM

China Jo-Jo Drugstores Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
147.13M 150.83M 154.54M 154.6M 154.66M 151.74M 148.81M 196.68M 201.58M 243.71M 246.59M 196.38M 188.96M 141.32M 133.13M 127.77M 125.59M 123.1M
Cost of Revenue
117.35M 120.39M 123.43M 122.4M 121.37M 117.95M 114.53M 149.95M 152.98M 188.17M 191.81M 156.56M 151.62M 112.36M 103.89M 99.2M 97.83M 95.66M
Gross Profit
29.77M 30.44M 31.11M 32.2M 33.29M 33.79M 34.28M 46.72M 48.6M 55.54M 54.78M 39.82M 37.35M 28.96M 29.24M 28.57M 27.76M 27.45M
Operating Income
-6.01M -4.77M -3.53M -11.48M -19.42M -20.18M -20.93M -13.14M -4.32M -4.19M -3.82M -1.61M -6.95M -7.98M -7.94M -11.27M -4.35M -4.44M
Interest Income
442.97K 442.97K 442.97K 509.88K 733.31K 775.68K 818.05K 544.5K 270.94K 251.82K 232.7K 303.01K 403.12K 567.54K 707.88K 947.05K 1.03M 1.18M
Pretax Income
-5.55M -4.86M -4.17M -12.82M -21.47M -21.11M -20.74M -12.28M -2.91M -3.09M -3.15M -1.49M -6.86M -8.14M -8.34M -11.36M -4.61M -4.4M
Net Income
-5.59M -4.91M -4.23M -12.85M -21.47M -21.3M -21.14M -13.8M -4.99M -4.95M -4.79M -2.03M -6.85M -8.12M -8.38M -11.19M -4.37M -4.07M
Selling & General & Admin
35.79M 35.21M 34.64M 43.68M 52.72M 53.96M 55.21M 59.86M 52.92M 59.73M 58.6M 41.89M 44.76M 37.41M 37.85M 39.43M 31.7M 31.47M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 148.79K 148.79K 148.79K 148.79K n/a -43.52K -43.52K 6.5K 6.5K 50.02K -22.2K
Operating Expenses
35.57M 35.68M 35.78M 45.75M 55.72M 55.78M 55.84M 59.68M 51.91M 59.22M 58.44M 41.74M 44.62M 37.27M 37.85M 39.43M 31.7M 31.47M
Interest Expense
13.3K 13.3K 13.3K n/a n/a n/a n/a n/a n/a n/a n/a 100.21K 210.11K 327.8K 455.19K 1.05M 943.6K 825.9K
Selling & Marketing Expenses
19.96M 19.93M 19.9M 24.29M 28.69M 28.93M 29.18M 30.65M 32.11M 31.5M 30.88M 28.03M 27.5M 27.33M 26.95M 26.67M 24.09M 24.1M
Cost & Expenses
152.92M 156.07M 159.22M 168.15M 177.09M 173.73M 170.37M 209.63M 204.89M 247.38M 250.25M 198.3M 196.24M 149.63M 141.74M 138.62M 129.53M 127.13M
Income Tax Expense
34.29K 48.58K 62.86K 73.14K 83.42K 283.23K 483.03K 1.56M 2.08M 1.87M 1.65M 544.86K -1.07K -23.97K 31.64K 40.55K 40.76K 65.44K
Shares Outstanding (Basic)
5.38M 5.38M 1.69M 1.69M 1.2M 1.2M 792.95K 792.95K 226.7K 226.7K 14.5K 173.97K 173.97K 109.48K 3.48M 3.44M 3.11M 2.87M
Shares Outstanding (Diluted)
5.38M 5.38M 1.69M 1.69M 1.2M 1.2M 792.95K 792.95K 226.7K 226.7K 200.33K 173.97K 173.97K 173.97K 3.48M 3.44M 3.16M 2.87M
EPS (Basic)
-2.38 -2.56 -2.74 -14.71 -26.68 -27.6 -28.52 -217.64 -213.11 -213.31 -213.2 -11.18 -4.59 -3.57 -2.51 -3.55 -1.48 -1.44
EPS (Diluted)
-2.38 -2.56 -2.74 -14.71 -26.68 -27.6 -28.52 -30.19 -25.66 -25.86 -25.31 -10.74 -4.15 -3.12 -2.5 -3.54 -1.47 -1.44
EBITDA
-5.06M -3.91M -2.76M -10.9M -19.04M -19.63M -20.23M -11.89M -2.85M -2.36M -1.96M -410.58K -5.43M -6.54M -6.08M -7.57M -740.44K -609K
EBIT
-5.75M -4.51M -3.27M -11.48M -19.42M -20.18M -20.93M -12.59M -3.78M -3.65M -3.27M -1.84M -7M -7.93M -7.89M -9.73M -3.09M -3.01M
Depreciation & Amortization
951.97K 861.97K 771.97K 580.54K 389.11K 543.89K 698.67K 1.25M 1.48M 1.84M 1.86M 1.43M 1.56M 1.39M 1.81M 2.17M 2.29M 2.34M